Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Patients seek this protocol for: BPC-157 / TB-500 are administered via subcutaneous injection
Going slowly reduces the chance you will feel a sting
However, it has not received approval as a medical product from the US Food and Drug Administration (FDA), and studies on its use in humans are lacking
It has also been shown to upregulate the expression of the early growth response gene-1 (Egr-1), a transcription factor that orchestrates the expression of multiple growth factors involved in wo Research Evidence Promotes VEGFR2-mediated angiogenesis in preclinical wound models (McGuire et al., 2025)Stimulates fibroblast migration and tendon outgrowth in ex vivo explant studies (Sikiric et al., 2021)Upregulates Egr-1 transcription factor, driving growth factor expression cascadeDemonstrates stability under physiological conditions due to high proline contentModulates nitric oxide signaling pathways in gastrointestinal and vascular tissue models Bottom line: BPC-157 is one of the most extensively studied synthetic peptides in preclinical regenerative research
US$ 24.93
US$ 25.41
US$ 24.65
